Jorge Gómez

5.0k total citations · 1 hit paper
96 papers, 3.5k citations indexed

About

Jorge Gómez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jorge Gómez has authored 96 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Jorge Gómez's work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (24 papers) and Lung Cancer Research Studies (16 papers). Jorge Gómez is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (24 papers) and Lung Cancer Research Studies (16 papers). Jorge Gómez collaborates with scholars based in United States, Spain and Italy. Jorge Gómez's co-authors include Mark G. Kris, Vincent A. Miller, Lee M. Krug, Barbara Pizzo, Christopher G. Azzoli, Naiyer A. Rizvi, Robert T. Heelan, Leslie B. Tyson, William Pao and Ennapadam Venkatraman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jorge Gómez

95 papers receiving 3.4k citations

Hit Papers

Bronchioloalveolar Pathologic Subtype and Smoking History... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
    2004 628 citations Vincent A. Miller, Mark G. Kris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Gómez United States 27 1.6k 1.5k 642 450 327 96 3.5k
Tanya M. Wildes United States 34 1.6k 1.0× 546 0.4× 653 1.0× 471 1.0× 839 2.6× 225 3.6k
Saro H. Armenian United States 44 1.7k 1.1× 826 0.5× 536 0.8× 1.5k 3.2× 152 0.5× 238 5.9k
Soo‐Mee Bang South Korea 35 2.3k 1.4× 1.1k 0.7× 682 1.1× 431 1.0× 77 0.2× 295 5.0k
Kim Cocks United Kingdom 31 1.9k 1.2× 633 0.4× 497 0.8× 362 0.8× 104 0.3× 112 3.7k
Annouschka Laenen Belgium 37 1.1k 0.7× 793 0.5× 464 0.7× 274 0.6× 150 0.5× 304 4.6k
Anna K.L. Reyners Netherlands 29 1.0k 0.6× 657 0.4× 582 0.9× 313 0.7× 80 0.2× 129 2.5k
Ulrich Wedding Germany 30 1.5k 0.9× 808 0.5× 227 0.4× 722 1.6× 1.2k 3.5× 156 3.5k
Wen‐Chi Chou Taiwan 26 1.3k 0.8× 612 0.4× 233 0.4× 1.0k 2.3× 182 0.6× 244 3.0k
Jingxia Liu United States 35 1.3k 0.8× 806 0.5× 488 0.8× 515 1.1× 70 0.2× 231 4.1k
Francesco Ferraù Italy 28 929 0.6× 554 0.4× 421 0.7× 162 0.4× 189 0.6× 148 2.8k

Countries citing papers authored by Jorge Gómez

Since Specialization
Citations

This map shows the geographic impact of Jorge Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Gómez more than expected).

Fields of papers citing papers by Jorge Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Gómez. The network helps show where Jorge Gómez may publish in the future.

Co-authorship network of co-authors of Jorge Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Gómez. A scholar is included among the top collaborators of Jorge Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Gómez. Jorge Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuente, Rocío, Stuart M. Lichtman, Jorge Gómez, et al.. (2024). EP.06D.04 Prognostic Value of Variant Allele Frequency in Circulating Tumor DNA for Survival Outcomes in Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S502–S503. 1 indexed citations
2.
Kushare, Indranil, et al.. (2021). Causes of delayed diagnosis of posterior ankle impingement in the pediatric and adolescent population. The Foot. 47. 101799–101799. 1 indexed citations
3.
4.
Cho, Byoung Chul, Dongwook Kim, Jin Sun Lee, et al.. (2020). 1258O Amivantamab (JNJ-61186372), an EGFR-MET bispecific antibody, in combination with lazertinib, a 3rd-generation tyrosine kinase inhibitor (TKI), in advanced EGFR NSCLC. Annals of Oncology. 31. S813–S813. 32 indexed citations
5.
Rocha‐de‐Lossada, Carlos, et al.. (2020). Infiltrative optic neuropathy as a relapse of acute lymphoblastic leukemia. Journal Français d Ophtalmologie. 44(2). 293–295. 2 indexed citations
6.
7.
Yendamuri, Sai, Mark Hennon, Jorge Gómez, et al.. (2016). Minimally invasive rib-sparing video-assisted thoracoscopic surgery resections with high-dose-rate intraoperative brachytherapy for selected chest wall tumors. Practical Radiation Oncology. 6(6). e329–e335. 2 indexed citations
8.
Malhotra, Jyoti, Grace Mhango, Jorge Gómez, et al.. (2015). Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER–Medicare analysis. Annals of Oncology. 26(4). 768–773. 25 indexed citations
9.
Remark, Romain, Christian Becker, Jorge Gómez, et al.. (2014). The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome. American Journal of Respiratory and Critical Care Medicine. 191(4). 377–390. 205 indexed citations
10.
11.
Santos, Edgardo S., Jorge Gómez, & Luis E. Raez. (2011). Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor. Investigational New Drugs. 30(3). 1261–1269. 15 indexed citations
12.
Bastos, Bruno R., Georges F. Hatoum, Gail Walker, et al.. (2010). Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(4). 533–539. 15 indexed citations
13.
Lally, Brian E., Jean L. Wright, Leonidas G. Koniaris, et al.. (2010). Is Radiation Therapy Becoming More Effective in Treating Non-small Cell Lung Cancer?. International Journal of Radiation Oncology*Biology*Physics. 78(3). S201–S201. 1 indexed citations
14.
Cassileth, Barrie R., Gary Deng, Jorge Gómez, et al.. (2007). Complementary Therapies and Integrative Oncology in Lung Cancer. CHEST Journal. 132(3). 340S–354S. 68 indexed citations
15.
Milton, Daniel T., Gregory J. Riely, Christopher G. Azzoli, et al.. (2007). Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer. Cancer. 110(3). 599–605. 81 indexed citations
16.
Fury, Matthew G., David B. Solit, Yungpo Bernard Su, et al.. (2006). A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 59(4). 467–475. 52 indexed citations
17.
Krug, Lee M., John P. Crapanzano, Christopher G. Azzoli, et al.. (2005). Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein. Cancer. 103(10). 2128–2131. 117 indexed citations
18.
Gómez, Jorge. (2004). Violent crime and outdoor physical activity among inner-city youth. Preventive Medicine. 39(5). 876–881. 285 indexed citations
19.
Pérez-Soler, Román, Bonnie L. Kemp, Qing Wu, et al.. (2000). Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.. PubMed. 6(12). 4932–8. 63 indexed citations
20.
Gómez, Jorge, et al.. (1999). Current Use of Adequate Preparticipation History Forms for Heart Disease Screening of High School Athletes. Archives of Pediatrics and Adolescent Medicine. 153(7). 723–723. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanya M. Wildes Breakdown of academic impact, for papers by Saro H. Armenian Breakdown of academic impact, for papers by Soo‐Mee Bang Breakdown of academic impact, for papers by Kim Cocks Breakdown of academic impact, for papers by Annouschka Laenen Breakdown of academic impact, for papers by Anna K.L. Reyners Breakdown of academic impact, for papers by Ulrich Wedding Breakdown of academic impact, for papers by Wen‐Chi Chou Breakdown of academic impact, for papers by Jingxia Liu Breakdown of academic impact, for papers by Francesco Ferraù
Rankless by CCL
2026